Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term p53 Genes. Found 8 abstracts

Teye EK, Sido A, Xin P, Finnberg NK, Gokare P, Kawasawa YI, Salzberg AC, Shimko S, Bayerl M, Ehmann WC, Claxton DF, Rybka WB, Drabick JJ, Wang HG, Abraham T, El-Deiry WS, Brodsky RA, J Hohl R, Pu JJ. PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features. Oncotarget. 2017 May 02;8(18):29887-905.   PMCID: PMC5444711
Menges CW, Kadariya Y, Altomare D, Talarchek J, Neumann-Domer E, Wu Y, Xiao GH, Shapiro IM, Kolev VN, Pachter JA, Klein-Szanto AJ, Testa JR. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. Cancer Res. 2014 Feb 15;74(4):1261-71.   PMCID: PMC3945416
Pimkina J, Murphy ME. ARF, autophagy and tumor suppression. Autophagy. 2009 Apr;5(3):397-9.   PMCID: PMC2667648
Adams PD. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene. 2007 Aug;397(1-2):84-93.
Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M, Giaccia A. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol. 2001 Feb;21(4):1297-310.
Murphy ME. The battle between tumor suppressors: is gene therapy using p16(INK4a) more efficacious than p53 for treatment of ovarian carcinoma?. Clin Cancer Res. 2001 Jun;7(6):1487-9.
St John LS, Sauter ER, Herlyn M, Litwin S, Adler-Storthz K. Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53. Cancer Gene Ther. 2000 May;7(5):749-56.
Cairns P, Sidransky D. Molecular methods for the diagnosis of cancer. Biochimica et biophysica acta. 1999 Mar 25;1423(2):C11-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term p53 Genes

p53 Genes genetics metabolism Human Biological Models physiology Signal Transduction Mice Non-US Gov't Support Neoplasms Neoplastic Cell Transformation Mutation SCID Mice therapy Protein p53 methods Cultured Tumor Cells Cell Line Apoptosis US Gov't Support-PHS Female Neoplasm Transplantation pathology Cell Nucleus Cell Cycle Proteins Myelodysplastic Syndromes Messenger RNA Phosphotransferases Time Factors Leukemic Gene Expression Regulation Pleural Neoplasms Transgenic Mice Histones Retinoblastoma Genes Molecular Chaperones Autophagy Gene Silencing Cell Hypoxia analysis Computational Biology Myeloid Leukemia-Acute alpha-Fetoproteins Transgenes Phosphorylation pharmacology Gene Expression Profiling Tumor Suppressor Protein p53 Gene Knockdown Techniques leukemogenesis Microsatellite Repeats Animal Male Sensitivity and Specificity Cell Division Heterochromatin Bone Marrow Proto-Oncogene Proteins c-met Immunoblotting US Gov't Support-Non-PHS Exons Antineoplastic Agents Ovarian Neoplasms MicroRNAs Spindle Apparatus Acetylation Introns Protein p16 Mds AML with myelodysplasia-related changes (AML-MRC) Tumor Suppressor Genes Genomic Instability Precipitin Tests Mesothelioma Carcinoembryonic Antigen Proto-Oncogene Proteins DNA Sequence Analysis Neurofibromatosis 2 Genes Flow Cytometry Cell Cycle PIGN gene expression aberration Chloroquine ras Genes diagnosis Neoplastic Stem Cells Nuclear Proteins Hela Cells Chromatin Assembly and Disassembly Genetic Models genomic instability Squamous Cell Carcinoma CA-125 Antigen ADP-Ribosylation Factor 1 Tumor Suppressor Proteins Disease Progression blood chemistry Neoplasm Invasiveness Histone Deacetylases Biological Tumor Markers Prostate-Specific Antigen Keratinocytes Chorionic Gonadotropin Adenoviridae Genetic Transduction antagonists & inhibitors Gene Therapy Binding Sites Transcription Factors Asbestos Experimental Neoplasms Cyclins Cell Proliferation Cell Aging Aging Trans-Activation (Genetics) DNA Damage prevention & control
Last updated on Wednesday, February 05, 2020